BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 28, 2017
View Archived Issues
GSK to incorporate Owlstone's Breath Biopsy platform into danirixin clinical program
Read More
Bicycle Therapeutics creates novel peptide-toxin conjugates specific for MT1-MMP
Read More
aTyr Pharma initiates dosing in first-in-human trial of iMod.Fc
Read More
Novel HIV integrase inhibitors discovered at ViiV Healthcare
Read More
Sunshine Lake Pharma patents novel memantine prodrugs
Read More
Catalyst Pharmaceuticals reports topline results from phase III study of Firdapse
Read More
Kyowa Hakko Kirin licenses tenapanor rights in Japan from Ardelyx
Read More
FDA grants priority review to Dova's NDA for avatrombopag
Read More
Otonomy discontinues commercial support for Otiprio, focuses resources on otology pipeline
Read More
EMA accepts Macrilen MAA for adult growth hormone deficiency
Read More
Biogen and Alkermes collaborate to develop and commercialize ALKS-8700 for MS
Read More
VE-2851, a promising novel thrombin inhibitor with low bleeding risk
Read More
FDA grants fast track designation to Stealth Biotherapeutics' elamipretide
Read More
Medeor Therapeutics closes series B financing
Read More
Prima BioMed changes name to Immutep
Read More
EMA accepts Tagrisso submission in first-line EGFR-mutated NSCLC
Read More
KY-1044 elicits long-term in vivo antitumor efficacy
Read More
AbbVie announces launch of Maviret in Japan
Read More
Eureka Therapeutics cleared by FDA for phase I study of ET-190L1-Artemis T cells
Read More
In vitro and in vivo characterization of the novel anti-CTLA-4 antibody ADU-1604
Read More
Long-lasting neutralizing antibody responses seen with dengue vaccine KD-382 in cynomolgus monkeys
Read More
Novel gene variations linked to common forms of epilepsy
Read More